Evidence item
The primary passage directly supports the healthy UK sample and in-vitro proliferative-cell percentage endpoint. DIRECT_TEXT
Source: NeuroFit randomized trial in healthy middle-aged UK adults · locator {} · excerpt hash sha256:e591e4a94a56f66d56611bd8078d17a8f7d45ebc143c74b7ef64317e4bb48708
Exact excerpt
We conducted a three-month randomised controlled trial in healthy middle-aged adults in the UK (n = 52) ... significant intervention-by-time effects were detected ... for the percentage of proliferative cells in vitro.
Linked claims
| Claim | Direction | Relevance | Steps | Counted |
|---|---|---|---|---|
| f098784f | SUPPORT | DIRECT | 0 | yes |
Audits
None.